CVE-2026-120286nerves-hub nerves_hub_web missing authorization
CVE-2026-120286 is a missing authorization in nerves-hub nerves_hub_web, rated medium (5.3 on CVSS 4.0).
Why this priority: Medium severity, with no exploitation signal.
Published · Updated · NVD status: Received
What it is
An action never checks whether the caller is allowed to perform it.
How it is reached
An attacker can exploit it over the network, with an ordinary user account, and nobody has to click anything.
What an attacker gains
The direct impact is limited: partial access to data or a partial outage. In practice, this kind of flaw lets an attacker reach data or actions their role should not allow. The damage can spread past the vulnerable component into others.
Is it being exploited?
There is no public report of exploitation yet.
What to do
- Upgrade nerves-hub nerves_hub_web to 2.5.3 or later.
- Until it is patched, review who holds accounts that can reach it.
Description from NVD
Missing Authorization vulnerability in the device and deployment group pages in nerves-hub nerves_hub_web allows an authenticated organization member with the view role to change devices and deployment groups via LiveView events reserved for the manage role. The event handlers that add and delete device certificates, add and remove tags, overwrite or clear a device's manual location, remove a device from its deployment group, move matched devices into a deployment group or remove unmatched ones, import devices from a CSV, and start, retry or delete firmware delta builds carry out the change without calling authorized!/2, and the pages render the controls to every member.
A view member can add a certificate that lets whoever holds its key connect as the device, delete a certificate so the device can no longer authenticate with it, and change which deployment group, and so which firmware release, a device receives. Everything stays within the organizations the member belongs to.
This issue affects nerves_hub: from 1.0.0 before 2.5.3.
What this means for your architecture.
A CVE names a product. Whether it matters depends on where that product sits in your systems: what reaches it, which trust boundary it guards and what it can reach once compromised. Veriom maps your components, their relationships and your trust boundaries from your code, cloud and delivery evidence, so you can see where a component like this sits. The radar itself does not look at your systems.
Components it touches
- Permission checks in APIs and admin surfaces. The flaw sits between one role or tenant and another.
- Multi-tenant services. The flaw sits between one role or tenant and another.
Trust boundaries in play
- Authenticated network access. An account is needed, so exposure follows who can sign in: customers, partners or staff.
- Isolation between components. The impact crosses out of the vulnerable component into others it should be isolated from.
- Between one role or tenant and another. An attacker who crosses it can reach data or actions their role should not allow.
Questions to answer about your own systems
- Where does nerves-hub nerves_hub_web run in your systems, and at which version?
- Which of those instances can be reached from the internet or partner networks?
- What can it reach once compromised: which data stores, secrets and services?
Read more
Patches and commits
Sources
- CVE records and CVSS scores from the NVD CVE API. This product uses the NVD API but is not endorsed or certified by the NVD.
- Exploitation status from CISA’s Known Exploited Vulnerabilities catalog.
- Exploit likelihood from FIRST’s Exploit Prediction Scoring System (EPSS), refreshed daily.
- Explanations are written by Veriom from fixed templates over each record’s data, not by a person reviewing each CVE. Descriptions are quoted from the records as published.